2-Week Course Of Sleep Aid Increases CPAP Adherence In OSA Patients At 6 Months, Walter Reed Army Institute of Research Study

EurekAlert! -- ATS 2009, SAN DIEGO—New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.